Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05870982 · ClinicalTrials.gov registry record · NA
Early vs. Late Time Restricted Eating vs. Daily Caloric Restriction
A NA study of Overweight and Obesity, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT05870982: Recruiting NA study of Overweight and Obesity, sponsored by University of Colorado, Denver.
NCT05870982 is a NA study of Overweight and Obesity that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 162 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05870982, a NA study of Overweight and Obesity, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about time restricted eating as a weight loss intervention in adults with obesity. The main questions it aims to answer are: 1. How does the timing of the eating window (early vs late time restricted eating) affect weight loss and changes in metabolic risk factors? 2. How does time restricted eating compare to standard of care (daily caloric restriction) for weight loss and changes in metabolic risk factors? Participants will be randomly assigned to either early time restricted eating, late time restricted eating, or daily caloric restriction. 1. They will be asked to follow the assigned dietary strategy for 1 year and will receive a group-based program for instruction and support. 2. They will be asked at several times during the year to have their weight and body composition measured, provide blood samples, track their food, and wear monitors for physical activity and sleep.
Primary Outcome
Body weight will be measured using a digital scale at baseline, weeks 14, 26 and 52. The primary outcome will be change in weight from baseline to 26 weeks.
Conditions Studied
Interventions
- BEHAVIORAL Early TRE
- BEHAVIORAL Late TRE
- BEHAVIORAL DCR
Study Locations (1)
Colorado
- University of Colorado Anschutz Health and Wellness Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT05870982 shows while recruiting
NCT05870982 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Early TRE is the first listed.
NCT05870982 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05870982 about?
NCT05870982 is a clinical study titled "Early vs. Late Time Restricted Eating vs. Daily Caloric Restriction". The goal of this clinical trial is to learn about time restricted eating as a weight loss intervention in adults with obesity. The main questions it aims to answer are: 1. How does the timing of the eating window (early vs late time restricted eating) affect weight loss and changes in metabolic ris...
What is the current status of trial NCT05870982?
This trial is currently recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2023-07-11. Estimated completion is 2027-09.
What conditions does trial NCT05870982 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT05870982?
The interventions under investigation include: Early TRE (BEHAVIORAL), Late TRE (BEHAVIORAL), DCR (BEHAVIORAL).
Who is sponsoring clinical trial NCT05870982?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05870982 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05870982's enrollment target sits among peer trials
162 41st of 115 higher than 75 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI